AlphaGrep UK’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$978K Buy
22,906
+11,245
+96% +$611K 0.29% 43
2026
Q1
$732K Sell
11,661
-276
-2% -$22.1K 0.21% 99
2025
Q4
$1.14M Buy
+11,937
New +$1.17M 0.38% 24

Other funds holding BSX

AlphaGrep UK's BSX Position: Q2 2026 in Review

AlphaGrep UK increased its Boston Scientific (BSX) stake by 96% in Q2 2026, buying an estimated $611K and bringing the position to 22,906 shares worth $978K. The position accounts for 0.29% of the portfolio, ranked #43.

AlphaGrep UK first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.14M in Q4 2025. 1,381 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • AlphaGrep UK held 22,906 shares of Boston Scientific worth $978K as of Q2 2026.
  • AlphaGrep UK bought 11,245 Boston Scientific shares in Q2 2026, an estimated $611K.
  • Boston Scientific made up 0.29% of AlphaGrep UK's portfolio in Q2 2026, its #43 holding.
  • AlphaGrep UK first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • AlphaGrep UK's Boston Scientific position peaked at $1.14M in Q4 2025.
  • 1,381 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.